Benjamin Drapkin, M.D., Ph.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Division of Hematology and Oncology. He specializes in the care of lung cancer patients, with a focus on small cell lung cancer (SCLC).

Dr. Drapkin earned his medical degree and his doctoral degree in cell biology and genetics through the Tri-Institutional M.D.-Ph.D. Program sponsored by Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. He completed a residency in internal medicine at Massachusetts General Hospital and received advanced training in the care of cancer patients through the Dana-Farber/Mass General Brigham Fellowship in hematology/oncology.

Certified by the American Board of Internal Medicine in medical oncology, he joined the UT Southwestern faculty in 2020.

Dr. Drapkin’s research focuses on SCLC clinical trials and translational research in SCLC and other aggressive neuroendocrine tumors. His laboratory leverages patient-derived xenograft (PDX) models to discover new targets and develop new therapies for these deadly diseases. He has published numerous academic articles.

In 2020 he received the University of Texas Lung Cancer SPORE Career Enhancement Program Award and the K08 Mentored Clinical Scientist Research Career Development Award.


Medical School
Cornell University Medical College (2010)
Massachusetts General Hospital (2013), Internal Medicine
Dana-Farber Cancer Institute (2019), Hematology Oncology